nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—L-DOPA—Liothyronine—hypothyroidism	0.435	1	CrCrCtD
Droxidopa—SLC16A10—Liothyronine—hypothyroidism	0.211	0.506	CbGbCtD
Droxidopa—SLC16A10—Liotrix—hypothyroidism	0.206	0.494	CbGbCtD
Droxidopa—ADRB3—brown adipose tissue—hypothyroidism	0.0116	0.283	CbGeAlD
Droxidopa—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00712	0.139	CcSEcCtD
Droxidopa—Arrhythmia—Liothyronine—hypothyroidism	0.00399	0.0781	CcSEcCtD
Droxidopa—DDC—nerve—hypothyroidism	0.00369	0.0904	CbGeAlD
Droxidopa—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.0035	0.0685	CcSEcCtD
Droxidopa—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.0035	0.0685	CcSEcCtD
Droxidopa—Hypertension—Liothyronine—hypothyroidism	0.00336	0.0657	CcSEcCtD
Droxidopa—Cardiac failure congestive—Liotrix—hypothyroidism	0.00257	0.0504	CcSEcCtD
Droxidopa—Arrhythmia—Levothyroxine—hypothyroidism	0.00196	0.0384	CcSEcCtD
Droxidopa—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00196	0.0384	CcSEcCtD
Droxidopa—PAH—blood—hypothyroidism	0.00179	0.0439	CbGeAlD
Droxidopa—SLC6A2—nerve—hypothyroidism	0.00176	0.043	CbGeAlD
Droxidopa—Confusional state—Dextrothyroxine—hypothyroidism	0.00157	0.0308	CcSEcCtD
Droxidopa—Confusional state—Levothyroxine—hypothyroidism	0.00157	0.0308	CcSEcCtD
Droxidopa—Shock—Levothyroxine—hypothyroidism	0.00153	0.03	CcSEcCtD
Droxidopa—Shock—Dextrothyroxine—hypothyroidism	0.00153	0.03	CcSEcCtD
Droxidopa—Arrhythmia—Liotrix—hypothyroidism	0.00144	0.0282	CcSEcCtD
Droxidopa—PAH—liver—hypothyroidism	0.0014	0.0343	CbGeAlD
Droxidopa—ADRB3—female gonad—hypothyroidism	0.00131	0.032	CbGeAlD
Droxidopa—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00128	0.0252	CcSEcCtD
Droxidopa—Feeling abnormal—Levothyroxine—hypothyroidism	0.00128	0.0252	CcSEcCtD
Droxidopa—Syncope—Liotrix—hypothyroidism	0.00126	0.0247	CcSEcCtD
Droxidopa—Loss of consciousness—Liotrix—hypothyroidism	0.00123	0.0242	CcSEcCtD
Droxidopa—Hypertension—Liotrix—hypothyroidism	0.00121	0.0237	CcSEcCtD
Droxidopa—Confusional state—Liotrix—hypothyroidism	0.00116	0.0226	CcSEcCtD
Droxidopa—Shock—Liotrix—hypothyroidism	0.00113	0.0221	CcSEcCtD
Droxidopa—DDC—adrenal gland—hypothyroidism	0.00102	0.025	CbGeAlD
Droxidopa—Headache—Dextrothyroxine—hypothyroidism	0.000977	0.0191	CcSEcCtD
Droxidopa—Headache—Levothyroxine—hypothyroidism	0.000977	0.0191	CcSEcCtD
Droxidopa—Feeling abnormal—Liotrix—hypothyroidism	0.000945	0.0185	CcSEcCtD
Droxidopa—Nausea—Dextrothyroxine—hypothyroidism	0.000926	0.0181	CcSEcCtD
Droxidopa—Nausea—Levothyroxine—hypothyroidism	0.000926	0.0181	CcSEcCtD
Droxidopa—DDC—testis—hypothyroidism	0.000846	0.0207	CbGeAlD
Droxidopa—SLC16A10—gonad—hypothyroidism	0.000805	0.0197	CbGeAlD
Droxidopa—DDC—liver—hypothyroidism	0.0008	0.0196	CbGeAlD
Droxidopa—ADRB1—heart—hypothyroidism	0.000768	0.0188	CbGeAlD
Droxidopa—Dizziness—Liotrix—hypothyroidism	0.000758	0.0148	CcSEcCtD
Droxidopa—ADRB1—cardiovascular system—hypothyroidism	0.000725	0.0177	CbGeAlD
Droxidopa—Headache—Liotrix—hypothyroidism	0.000718	0.0141	CcSEcCtD
Droxidopa—SLC16A10—blood—hypothyroidism	0.000702	0.0172	CbGeAlD
Droxidopa—Nausea—Liotrix—hypothyroidism	0.000681	0.0133	CcSEcCtD
Droxidopa—SLC16A10—thyroid gland—hypothyroidism	0.000677	0.0166	CbGeAlD
Droxidopa—ADRA1A—heart—hypothyroidism	0.000607	0.0149	CbGeAlD
Droxidopa—ADRA2C—adrenal cortex—hypothyroidism	0.000598	0.0146	CbGeAlD
Droxidopa—SLC16A10—testis—hypothyroidism	0.00058	0.0142	CbGeAlD
Droxidopa—ADRA2C—heart—hypothyroidism	0.000579	0.0142	CbGeAlD
Droxidopa—ADRA1A—cardiovascular system—hypothyroidism	0.000573	0.014	CbGeAlD
Droxidopa—SLC6A2—gonad—hypothyroidism	0.000559	0.0137	CbGeAlD
Droxidopa—SLC16A10—liver—hypothyroidism	0.000549	0.0134	CbGeAlD
Droxidopa—SLC16A10—cerebellum—hypothyroidism	0.000536	0.0131	CbGeAlD
Droxidopa—SLC6A2—adrenal gland—hypothyroidism	0.000488	0.0119	CbGeAlD
Droxidopa—ADRA2C—pituitary gland—hypothyroidism	0.000483	0.0118	CbGeAlD
Droxidopa—ADRA2A—heart—hypothyroidism	0.000462	0.0113	CbGeAlD
Droxidopa—ADRA1A—adrenal gland—hypothyroidism	0.000453	0.0111	CbGeAlD
Droxidopa—ADRA1A—blood—hypothyroidism	0.000453	0.0111	CbGeAlD
Droxidopa—ADRA2C—adrenal gland—hypothyroidism	0.000432	0.0106	CbGeAlD
Droxidopa—ADRA2C—blood—hypothyroidism	0.000432	0.0106	CbGeAlD
Droxidopa—SLC6A2—testis—hypothyroidism	0.000403	0.00986	CbGeAlD
Droxidopa—ADRA2C—female gonad—hypothyroidism	0.000403	0.00985	CbGeAlD
Droxidopa—ADRA2A—gonad—hypothyroidism	0.000395	0.00967	CbGeAlD
Droxidopa—ADRA2A—pituitary gland—hypothyroidism	0.000386	0.00944	CbGeAlD
Droxidopa—ADRA2C—testis—hypothyroidism	0.000357	0.00874	CbGeAlD
Droxidopa—ADRA1A—liver—hypothyroidism	0.000354	0.00867	CbGeAlD
Droxidopa—ADRA1A—cerebellum—hypothyroidism	0.000346	0.00847	CbGeAlD
Droxidopa—ADRA2A—adrenal gland—hypothyroidism	0.000345	0.00843	CbGeAlD
Droxidopa—ADRA2A—blood—hypothyroidism	0.000345	0.00843	CbGeAlD
Droxidopa—ADRA2C—liver—hypothyroidism	0.000338	0.00826	CbGeAlD
Droxidopa—ADRA2A—thyroid gland—hypothyroidism	0.000333	0.00814	CbGeAlD
Droxidopa—ADRA2C—cerebellum—hypothyroidism	0.00033	0.00807	CbGeAlD
Droxidopa—ADRA2A—female gonad—hypothyroidism	0.000321	0.00786	CbGeAlD
Droxidopa—ADRA2A—testis—hypothyroidism	0.000285	0.00697	CbGeAlD
Droxidopa—ADRA2A—cerebellum—hypothyroidism	0.000263	0.00644	CbGeAlD
Droxidopa—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	5.67e-05	0.001	CbGpPWpGaD
Droxidopa—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	5.58e-05	0.000988	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—TRH—hypothyroidism	5.51e-05	0.000976	CbGpPWpGaD
Droxidopa—DDC—Metabolism—PIK3C2A—hypothyroidism	5.45e-05	0.000965	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.41e-05	0.000959	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CLTC—hypothyroidism	5.25e-05	0.00093	CbGpPWpGaD
Droxidopa—ADRB3—GPCR ligand binding—POMC—hypothyroidism	5.22e-05	0.000925	CbGpPWpGaD
Droxidopa—ADRA2B—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	5.12e-05	0.000908	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—AVP—hypothyroidism	5.12e-05	0.000907	CbGpPWpGaD
Droxidopa—ADRA2B—G alpha (i) signalling events—POMC—hypothyroidism	5.07e-05	0.000899	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—TRH—hypothyroidism	5.02e-05	0.000889	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—TRH—hypothyroidism	5e-05	0.000886	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—TRH—hypothyroidism	4.97e-05	0.000881	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	4.95e-05	0.000878	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ATP5O—hypothyroidism	4.95e-05	0.000878	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—TSHB—hypothyroidism	4.91e-05	0.00087	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—TRH—hypothyroidism	4.91e-05	0.00087	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—TSHR—hypothyroidism	4.91e-05	0.00087	CbGpPWpGaD
Droxidopa—ADRA2C—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	4.79e-05	0.000848	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—SH2B3—hypothyroidism	4.74e-05	0.00084	CbGpPWpGaD
Droxidopa—ADRA2C—G alpha (i) signalling events—POMC—hypothyroidism	4.74e-05	0.000839	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—AVP—hypothyroidism	4.66e-05	0.000826	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—TPO—hypothyroidism	4.66e-05	0.000825	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—TRH—hypothyroidism	4.64e-05	0.000823	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—AVP—hypothyroidism	4.62e-05	0.000819	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—VAV3—hypothyroidism	4.61e-05	0.000817	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	4.6e-05	0.000816	CbGpPWpGaD
Droxidopa—DDC—Metabolism—SLC5A5—hypothyroidism	4.57e-05	0.000811	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—TRH—hypothyroidism	4.57e-05	0.00081	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—AVP—hypothyroidism	4.56e-05	0.000808	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—TRH—hypothyroidism	4.56e-05	0.000807	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TRH—hypothyroidism	4.53e-05	0.000803	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—TRH—hypothyroidism	4.51e-05	0.0008	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—TSHR—hypothyroidism	4.47e-05	0.000792	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—TSHB—hypothyroidism	4.47e-05	0.000792	CbGpPWpGaD
Droxidopa—ADRA1D—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.47e-05	0.000791	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—TSHB—hypothyroidism	4.46e-05	0.00079	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—TSHR—hypothyroidism	4.46e-05	0.00079	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—TRH—hypothyroidism	4.46e-05	0.00079	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—AVP—hypothyroidism	4.44e-05	0.000787	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—TSHB—hypothyroidism	4.43e-05	0.000785	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—TSHR—hypothyroidism	4.43e-05	0.000785	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—TSHB—hypothyroidism	4.37e-05	0.000775	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—TSHR—hypothyroidism	4.37e-05	0.000775	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—AVP—hypothyroidism	4.32e-05	0.000765	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—VAV3—hypothyroidism	4.29e-05	0.00076	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—AVP—hypothyroidism	4.26e-05	0.000755	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—AVP—hypothyroidism	4.25e-05	0.000753	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—TRH—hypothyroidism	4.22e-05	0.000747	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—VAV3—hypothyroidism	4.18e-05	0.000742	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—TRH—hypothyroidism	4.15e-05	0.000735	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—TSHB—hypothyroidism	4.14e-05	0.000733	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—TSHR—hypothyroidism	4.14e-05	0.000733	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—TSHB—hypothyroidism	4.07e-05	0.000722	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—TSHR—hypothyroidism	4.07e-05	0.000722	CbGpPWpGaD
Droxidopa—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.07e-05	0.000721	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—TSHB—hypothyroidism	4.06e-05	0.000719	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—TSHR—hypothyroidism	4.06e-05	0.000719	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—TRH—hypothyroidism	4.06e-05	0.000719	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TSHB—hypothyroidism	4.04e-05	0.000716	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TSHR—hypothyroidism	4.04e-05	0.000716	CbGpPWpGaD
Droxidopa—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.03e-05	0.000714	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—AVP—hypothyroidism	4.03e-05	0.000714	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—TSHB—hypothyroidism	4.02e-05	0.000713	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—TSHR—hypothyroidism	4.02e-05	0.000713	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—VAV3—hypothyroidism	4.01e-05	0.00071	CbGpPWpGaD
Droxidopa—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	3.98e-05	0.000705	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—TSHR—hypothyroidism	3.97e-05	0.000704	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—TSHB—hypothyroidism	3.97e-05	0.000704	CbGpPWpGaD
Droxidopa—ADRA2A—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	3.89e-05	0.000689	CbGpPWpGaD
Droxidopa—ADRA2A—G alpha (i) signalling events—POMC—hypothyroidism	3.85e-05	0.000682	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—AVP—hypothyroidism	3.77e-05	0.000669	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—TRH—hypothyroidism	3.77e-05	0.000668	CbGpPWpGaD
Droxidopa—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	3.77e-05	0.000667	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—TSHB—hypothyroidism	3.76e-05	0.000666	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—TSHR—hypothyroidism	3.76e-05	0.000666	CbGpPWpGaD
Droxidopa—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	3.71e-05	0.000657	CbGpPWpGaD
Droxidopa—PAH—Metabolism—POMC—hypothyroidism	3.7e-05	0.000656	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—TSHR—hypothyroidism	3.7e-05	0.000655	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—TSHB—hypothyroidism	3.7e-05	0.000655	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—TRH—hypothyroidism	3.69e-05	0.000653	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—TSHB—hypothyroidism	3.62e-05	0.000641	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—TSHR—hypothyroidism	3.62e-05	0.000641	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—SH2B3—hypothyroidism	3.6e-05	0.000638	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—AVP—hypothyroidism	3.51e-05	0.000621	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—TRH—hypothyroidism	3.42e-05	0.000607	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CLTC—hypothyroidism	3.42e-05	0.000606	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—POMC—hypothyroidism	3.4e-05	0.000603	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—TSHB—hypothyroidism	3.36e-05	0.000596	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—TSHR—hypothyroidism	3.36e-05	0.000596	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	3.29e-05	0.000583	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—TSHB—hypothyroidism	3.29e-05	0.000582	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—TSHR—hypothyroidism	3.29e-05	0.000582	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—VAV3—hypothyroidism	3.25e-05	0.000577	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CLTC—hypothyroidism	3.11e-05	0.000552	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—POMC—hypothyroidism	3.1e-05	0.000549	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CLTC—hypothyroidism	3.09e-05	0.000547	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—POMC—hypothyroidism	3.07e-05	0.000544	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	3.06e-05	0.000542	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—TSHB—hypothyroidism	3.05e-05	0.000541	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—TSHR—hypothyroidism	3.05e-05	0.000541	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CLTC—hypothyroidism	3.05e-05	0.00054	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—POMC—hypothyroidism	3.03e-05	0.000537	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—VAV3—hypothyroidism	3e-05	0.000532	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TRH—hypothyroidism	2.95e-05	0.000523	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—POMC—hypothyroidism	2.95e-05	0.000523	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—AVP—hypothyroidism	2.89e-05	0.000512	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CLTC—hypothyroidism	2.88e-05	0.000511	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—POMC—hypothyroidism	2.87e-05	0.000508	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CLTC—hypothyroidism	2.84e-05	0.000503	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—POMC—hypothyroidism	2.82e-05	0.0005	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—VAV3—hypothyroidism	2.74e-05	0.000485	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—VAV3—hypothyroidism	2.73e-05	0.000483	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—VAV3—hypothyroidism	2.71e-05	0.00048	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TRH—hypothyroidism	2.69e-05	0.000477	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—POMC—hypothyroidism	2.68e-05	0.000475	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—VAV3—hypothyroidism	2.68e-05	0.000474	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—PRL—hypothyroidism	2.67e-05	0.000473	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TRH—hypothyroidism	2.67e-05	0.000472	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—TSHB—hypothyroidism	2.65e-05	0.00047	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—IGF1—hypothyroidism	2.64e-05	0.000468	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—AVP—hypothyroidism	2.64e-05	0.000467	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TSHB—hypothyroidism	2.63e-05	0.000466	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TRH—hypothyroidism	2.63e-05	0.000466	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TSHR—hypothyroidism	2.63e-05	0.000466	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—AVP—hypothyroidism	2.63e-05	0.000465	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—AVP—hypothyroidism	2.61e-05	0.000463	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—AVP—hypothyroidism	2.58e-05	0.000457	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—VAV3—hypothyroidism	2.53e-05	0.000449	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	2.52e-05	0.000446	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	2.51e-05	0.000444	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—VAV3—hypothyroidism	2.49e-05	0.000441	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TRH—hypothyroidism	2.49e-05	0.000441	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—VAV3—hypothyroidism	2.48e-05	0.00044	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—VAV3—hypothyroidism	2.47e-05	0.000438	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—IGF1—hypothyroidism	2.47e-05	0.000437	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—VAV3—hypothyroidism	2.46e-05	0.000436	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TRH—hypothyroidism	2.45e-05	0.000434	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—AVP—hypothyroidism	2.44e-05	0.000432	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—VAV3—hypothyroidism	2.43e-05	0.000431	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—AVP—hypothyroidism	2.4e-05	0.000425	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TSHR—hypothyroidism	2.4e-05	0.000425	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TSHB—hypothyroidism	2.4e-05	0.000425	CbGpPWpGaD
Droxidopa—DDC—Metabolism—POMC—hypothyroidism	2.39e-05	0.000424	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—AVP—hypothyroidism	2.39e-05	0.000424	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—AVP—hypothyroidism	2.38e-05	0.000422	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TSHR—hypothyroidism	2.38e-05	0.000421	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TSHB—hypothyroidism	2.38e-05	0.000421	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—AVP—hypothyroidism	2.37e-05	0.00042	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PIK3C2A—hypothyroidism	2.37e-05	0.000419	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TSHB—hypothyroidism	2.35e-05	0.000416	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SH2B3—hypothyroidism	2.35e-05	0.000416	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TSHR—hypothyroidism	2.35e-05	0.000416	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—AVP—hypothyroidism	2.34e-05	0.000415	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	2.34e-05	0.000415	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	2.33e-05	0.000413	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—VAV3—hypothyroidism	2.3e-05	0.000407	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—VAV3—hypothyroidism	2.26e-05	0.000401	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TSHB—hypothyroidism	2.22e-05	0.000393	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TSHR—hypothyroidism	2.22e-05	0.000393	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—AVP—hypothyroidism	2.21e-05	0.000392	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	2.21e-05	0.000392	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TSHB—hypothyroidism	2.18e-05	0.000387	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TSHR—hypothyroidism	2.18e-05	0.000387	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—AVP—hypothyroidism	2.18e-05	0.000386	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TRH—hypothyroidism	2.18e-05	0.000386	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—TSHB—hypothyroidism	2.16e-05	0.000382	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SH2B3—hypothyroidism	2.14e-05	0.000379	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	2.13e-05	0.000378	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SH2B3—hypothyroidism	2.12e-05	0.000375	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SH2B3—hypothyroidism	2.09e-05	0.000371	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	2.06e-05	0.000364	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TRH—hypothyroidism	2.02e-05	0.000358	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	2.01e-05	0.000356	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—IGF1—hypothyroidism	2e-05	0.000355	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—SLC5A5—hypothyroidism	1.99e-05	0.000352	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	1.98e-05	0.000351	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SH2B3—hypothyroidism	1.98e-05	0.000351	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SH2B3—hypothyroidism	1.95e-05	0.000345	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	1.94e-05	0.000344	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	1.94e-05	0.000344	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	1.94e-05	0.000343	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	1.92e-05	0.000341	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—POMC—hypothyroidism	1.92e-05	0.000341	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	1.87e-05	0.000331	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	1.8e-05	0.00032	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	1.8e-05	0.00032	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	1.8e-05	0.000319	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—POMC—hypothyroidism	1.75e-05	0.00031	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—POMC—hypothyroidism	1.75e-05	0.000309	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PRL—hypothyroidism	1.74e-05	0.000308	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—POMC—hypothyroidism	1.74e-05	0.000307	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	1.73e-05	0.000307	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—POMC—hypothyroidism	1.71e-05	0.000304	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—POMC—hypothyroidism	1.62e-05	0.000287	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—SLC5A5—hypothyroidism	1.61e-05	0.000286	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—VAV3—hypothyroidism	1.61e-05	0.000285	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	1.61e-05	0.000285	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—POMC—hypothyroidism	1.6e-05	0.000283	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—POMC—hypothyroidism	1.59e-05	0.000282	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PRL—hypothyroidism	1.59e-05	0.000281	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—POMC—hypothyroidism	1.58e-05	0.00028	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—POMC—hypothyroidism	1.58e-05	0.000279	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PRL—hypothyroidism	1.57e-05	0.000278	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—POMC—hypothyroidism	1.56e-05	0.000276	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PRL—hypothyroidism	1.55e-05	0.000275	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AVP—hypothyroidism	1.55e-05	0.000275	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IGF1—hypothyroidism	1.52e-05	0.00027	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—POMC—hypothyroidism	1.47e-05	0.000261	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PRL—hypothyroidism	1.47e-05	0.00026	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—VAV3—hypothyroidism	1.47e-05	0.00026	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—VAV3—hypothyroidism	1.45e-05	0.000258	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—POMC—hypothyroidism	1.45e-05	0.000257	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PRL—hypothyroidism	1.44e-05	0.000256	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—VAV3—hypothyroidism	1.44e-05	0.000254	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	1.42e-05	0.000251	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AVP—hypothyroidism	1.41e-05	0.00025	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AVP—hypothyroidism	1.4e-05	0.000248	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AVP—hypothyroidism	1.38e-05	0.000245	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—VAV3—hypothyroidism	1.36e-05	0.000241	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—VAV3—hypothyroidism	1.34e-05	0.000237	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	1.32e-05	0.000233	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AVP—hypothyroidism	1.31e-05	0.000232	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AVP—hypothyroidism	1.29e-05	0.000228	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	1.29e-05	0.000228	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PRL—hypothyroidism	1.28e-05	0.000227	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	1.2e-05	0.000212	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PRL—hypothyroidism	1.19e-05	0.000211	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	1.19e-05	0.00021	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AVP—hypothyroidism	1.14e-05	0.000203	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	1.1e-05	0.000195	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AVP—hypothyroidism	1.06e-05	0.000188	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—POMC—hypothyroidism	1.04e-05	0.000184	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—POMC—hypothyroidism	1.03e-05	0.000183	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IGF1—hypothyroidism	9.92e-06	0.000176	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—POMC—hypothyroidism	9.39e-06	0.000166	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—POMC—hypothyroidism	9.31e-06	0.000165	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—POMC—hypothyroidism	9.19e-06	0.000163	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IGF1—hypothyroidism	9.04e-06	0.00016	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IGF1—hypothyroidism	8.95e-06	0.000159	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IGF1—hypothyroidism	8.84e-06	0.000157	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—POMC—hypothyroidism	8.69e-06	0.000154	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—POMC—hypothyroidism	8.56e-06	0.000152	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—POMC—hypothyroidism	8.45e-06	0.00015	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IGF1—hypothyroidism	8.36e-06	0.000148	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IGF1—hypothyroidism	8.23e-06	0.000146	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—POMC—hypothyroidism	7.6e-06	0.000135	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	7.31e-06	0.00013	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—POMC—hypothyroidism	7.06e-06	0.000125	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	6.79e-06	0.00012	CbGpPWpGaD
